text:
Game of Thrones
6,907 Fans
In the Seven Kingdoms of Westeros, where summers span decades and winters can last a lifetime, the Great Houses (Stark, Baratheon, Targaryen, Lannister, Greyjoy, Arryn, Martell, Tully and Tyrell) fight among themselves for a right to rule the Iron Throne. Beyond the Wall and across the Narrow Sea bigger threats are rising until its a right moment to take a revenge. Based on R.R. Martin's novels.
Trivia Facts | Top Quotes | Goofs/Mistakes
- Author George R.R. Martin was asked if he had a resolution or ending to the seemingly endless conflict. He jokingly replied that the next book would just be a description of a cloud of dust or snow being driven by the wind across a vast graveyard full of tombstones.
- The series takes its name from the first novel in the book series "A Game of Thrones", which is actually known as "A Song of Ice and Fire." George R.R. Martin's story credit acknowledges the entire series under this title, rather than the title of individual volumes.
- Features actors from two different adaptations of "The Lord of the Rings": Peter Vaughan, who played Denethor in the BBC Radio adaptation; and Sean Bean, who played the character's son Boromir in the Peter Jackson films.
- Carice van Houten ("Melisandre") had previously been asked to audition for the role of Cersei Lannister but was unable to because she was filming Intruders.
- Yara Greyjoy, introduced in the second book and season, is named Asha in the books. The name was changed for the television series to avoid confusion with Osha. However, in the German dubbed version she is called Asha, like in the books. Similarly, Lysa Arryn's son Robert is named Robin in the series to avoid confusion with Robert Baratheon.
- Features ten actors from the "Harry Potter" film series: Bronson Webb ("Will") played an unnamed Slytherin student in the third film; Natalia Tena ("Osha") played Nymphadora Tonks; David Bradley ("Lord Walder Frey") played Argus Filch; Julian Glover ("Grand Maester Pycelle") voiced Aragog; Michelle Fairley ("Catelyn Stark") played Mrs. Granger in the seventh film; Ciarán Hinds ("Mance Rayder") played Aberforth Dumbledore; Ralph Ineson ("Dagmer Cleftjaw") played Amycus Carrow; Edward Tudor-Pole ("Protestor at King's Landing") played Mr. Borgin; Ian Whyte (II) ("Gregor Clegane") played Madame Maxime in full-body shots; Jim Broadbent (his role has not been revealed yet) played Professor Horace Slughorn. Stephen Dillane ("Stannis Baratheon") is also the father of Frank Dillane, who played the young Voldemort / Tom Riddle in Harry Potter and the Half-Blood Prince. "Potter" cast members Jamie Campbell Bower (young "Gellert Grindelwald") and Simon Fisher-Becker ("Fat Friar") were originally set to play Waymar Royce and the High Septon before being replaced by Rob Ostlere and David Verrey, respectively.
- The first season premiered on Sean Bean's birthday (April 17th).
- While most of the show is largely faithful to the books, composite characters do appear. The most prominent is the prostitute Ros, who is a composite of several named (Alayaya, Chataya, Kyra) and unnamed characters from the book series. Another composite character is the trader Spice King in Qarth, who appears in Season Two.
- SPOILER: Series author George R.R. Martin reported on his blog that after the filming of the episode in which Sansa's direwolf Lady is executed, the dog that played Lady, a Northern Inuit named Zunni, was adopted by Sophie Turner (IV), the actress who plays Sansa.
- In Westeros, bastards (also "natural child" or "baseborn") born to nobles are given surnames different than their father's, according to the region they were born in. These surnames are mostly associated with the geographic or climatic features of the respective regions: The Reach - Flowers; The Westerlands - Hill, The Iron Islands - Pyke, The Riverlands - Rivers, Dorne - Sand, The North - Snow, The Vale - Stone, The Stormlands - Storm; The Crownlands - Waters. These special surnames or "bastard names" apply only to noble-born bastards, who are openly acknowledged by their noble parent. Therefore, bastards both of whose parents are commoners, or noble-born bastards that are unacknowledged by their noble parent (like Gendry), cannot use the special surname. A noble-born bastard can be legitimized by royal decree, thus being considered as a trueborn child and changes the surname to the father's. However, the social stigma of the bastard may not always be lifted even after legitimization.
- Maester Aemon Targaryen of the Night's Watch is revealed to be blind in the novels. He was played by Peter Vaughan, who is legally partially blind himself.
- Liam Burke (III) was cast as Aerys II Targaryen, the "Mad King" in flashback scenes, but the scenes were cut.
- The official words of House Lannister, "Hear Me Roar!", are seldom mentioned. Their unofficial motto, "A Lannister always pays his debts", is often used, mostly in negative context, meaning that Lannisters always repay unkindness with unkindness.
- Dominic West and Perdita Weeks were offered major roles.
- According to the novels, the sigil of House Baratheon is a black stag with a crown above its head on a field of gold. In the TV series, the Baratheons' banner depicts a stag with a crown around its neck.
- During an interview for the second season, Sophie Turner (IV) ("Sansa Stark") said she was most looking forward to filming Sansa's relationship with Sandor Clegane--aka "The Hound"--played by Rory McCann.
- The first season used Northern Inuit dogs, a type specifically bred for wolf-like appearance, to stand in for the direwolves (the Stark's house sigil). However, since direwolves are known to be much larger than normal wolves, real wolves were digitally composited into scenes for Season 2. This strained the budget and the schedule, which is why there are only a handful of scenes with Grey Wind (Robb Stark's wolf), Summer (Bran Stark's wolf) and Shaggydog (Rickon Stark's wolf); Ghost, who belongs to Jon Snow, is shown in brief glimpses.
- Tamzin Merchant played Daenerys Targaryen in the pilot but was replaced by Emilia Clarke for the series. While the reason for Merchant's departure has not been made public, George R.R. Martin praised her performance as "wonderful" in his blog.
- SPOILER: Many of the characters have nicknames, mostly based on specific deed, behavior or physical feature of the person in question. The nicknames can be derogatory (Kingslayer) or for mockery (Brienne the Beauty). For example: Eddard Stark: Ned; Jaime Lannister: the Kingslayer; Tyrion Lannister: the Imp or Halfman; Varys: the Spider; Sandor Clegane: the Hound; Gregor Clegane: the Mountain that Rides (or simply the Mountain); Petyr Baelish: Littlefinger; Jeor Mormont: the Old Bear; Loras Tyrell: Knight of Flowers; Olenna Tyrell: Queen of Thorns; Roose Bolton: Leech Lord; Aerys Targaryen: the Mad King; Viserys Targaryen: the Beggar King; Theon Greyjoy: the Turncloak or Reek; Melisandre: the Red Woman; Vargo Hoat: the Goat; Robb Stark: the Young Wolf; Jon Snow: the White Wolf; Brienne: the Beauty; Qhorin: Halfhand; Mance Rayder: the King Beyond the Wall; Davos Seaworth: the Onion Knight; Jon Umber Sr.: Greatjon; Jon Umber Jr.: Smalljon; Eddison Tollett: Dolorous Edd; Samwell Tarly: the Slayer; Gerold Hightower: the White Bull; Arthur Dayne: Sword of the Morning; Brynden Tully: Blackfish; Oberyn Martell: the Red Viper; Oberyn Martell's bastard daughters: the Sand Snakes.
- Catelyn Stark was played in the pilot by Jennifer Ehle, but she dropped out when the series was picked up, and Michelle Fairley was cast.
- SPOILER: George R.R. Martin has stated that the infamous "Red Wedding" was the hardest chapter for him to write in "A Storm of Swords." He was so emotionally attached to the characters that he actually wrote the rest of the book first, then that chapter last. Executive Producers David Benioff and D.B. Weiss, upon reading it, declared it was one of the major reasons they decided to option the books for a TV series. Their dramatization differs from the book in a few details, most notably that Robb's wife is not present at the wedding, nor is she killed. Whether she is pregnant is unknown.
- In the year 2012, over 160 baby girls in the U.S. were legally named "Khaleesi", after the character in the show, although it is not the character's name (Daenerys) but a title.
- Producer David Benioff wanted the theme song to be the Lannister song "The Rains of Castamere." Co-producer D.B. Weiss convinced him not to do it.
- While the first two seasons roughly cover the novels "A Game of Thrones" and "A Clash of Kings" respectively, the third season covers about two-thirds of the third novel "A Storm of Swords." The fourth season covers the rest of "A Storm of Swords" and chapters from the fourth and fifth novels "A Feast for Crows" and "A Dance with Dragons". Finally, the fifth season covers almost entirely "A Feast for Crows", "A Dance With Dragons", and even early events of the unreleased sixth novel "The Winds of Winter".
- Emilia Clarke (Daenerys Targaryen) was doused in so much fake blood during the horse heart eating scene in season 1 that she got stuck to a toilet seat during a break.
- The show has three Doctor Who (UK) (2005) guest stars, each of whom participated in two-parters: Harry Lloyd ("Viserys Targaryen"), Iain Glen ("Jorah Mormont") and Thomas Brodie-Sangster ("Jojen Reed"). Both Lloyd and Sangster were in the same episodes.
- Thomas Brodie-Sangster, who plays the 13-year-old Jojen Reed, was 22 when cast in the role.
- The character Joffrey Baratheon is modeled after the unbalanced Roman emperor Caligula, whose four-year reign, by most accounts, was marked by extreme cruelty and sadism.
- Jack Gleeson (Joffrey) received a letter from author George R.R. Martin after the show aired, stating,"Congratulations on your marvelous performance, everyone hates you!"
- Natural brunette Emilia Clarke has stated that she has never dyed her hair for the show. Daenerys Targaryen's impressive platinum blonde locks are achieved via an elaborate wig and makeup system that takes considerable time to get into place.


text:
please go fast
I got the spiderman set in my last Big ol' Cornucopia If you want them, you can have them for the cost of shipping... PM me...
They aren't perfect, but they aren't used either.
My almost 3 year old loves these!
Looks like they need to create 80's Woot, what with the recent Roller Skates and Fanny Packs http://sport.woot.com/offers/high-sierra-passport-lumbar-pack-2

subset: commoncrawl


text:
When South African schoolgirl Melanie Olhaus went to Johannesburg airport to greet Olympic champion Chad le Clos on his arrival home from London, she brought with her a poster asking the gold medallist whether he would go to her high school dance with her.
The sign was made in hope rather than expectation - but amazingly the hunky swimmer has agreed to the request.
"I just started to cry. I was shaking and I was so nervous," admitted 17-year-old Melanie.
Chad became a household name when he beat Michael Phelps in the men's 200m butterfly final at the London Games, while his father's passionate antics poolside also kept television viewers entertained.
Melanie was so taken by the 20-year-old star that she skipped school for the day so that she could see him arrive back in his native land.
Her sign read: "Chad, will you be my matric dance date???" together with pictures of her and him holding his gold medal. The matric dance is for final-year students at Melanie's Glenvista High School in Johannesburg and is akin to the high school proms they have in America.
"He said he thinks he's in the country at that time and he'll try and make it," Melanie told the Beeld newspaper.
"I didn't have a matric dance date yet and I thought, 'why not?' He's just so gorgeous!"
Despite the fact that she skipped school to land the date, Melanie's principal Marius Robinson is not about to stand in the way of the schoolgirl's dream date.
"Let's just say it was an urgent personal appointment," he joked.
Melanie, meanwhile, said that her classmates could forget about having a dance with her date.
"No, no no. He's all mine," she laughed.


text:
Log in
Sign up
Log in
Sign up
How can we help?
You can also find more resources in our
Help Center
Select a category
Something is confusing
Something is broken
I have a suggestion
Other feedback
What is your email?
What is 1 + 3?
Send Message
Upgrade to remove ads
11 terms
Civics Ch. 23 Vocab. Buras
parliamentary government
a government in which an elected assembly has both legislative and executive powers
command economy
an economic system in which the government owns all means of production: land, buildings, factories, and machinery
the lower house if the federal assembly russia's government
theocratic republic
a government that has a constitution based on a strict interpretation of religion
a dictatorship that is run by a single person or by a small single person or by small group that consists if military officers
martial law
military law
ethnic groups
tribal groups
a political strategy that uses violence against people or property to achieve a goal
weapons of mass destruction
chemical, biological, and nuclear weapons that can kill large numbers of people
civil war
a war in which groups within a nation battle for power
nuclear proliferation
the spread of nuclear weapons to nations that do not have nuclear capabilities
Upgrade to remove ads


text:
This really is an amazing TV! I saw it the other day, playing Monsters Versus Aliens. I'm not such a fan of the film itself, but the colours were rich enough to make me want to lick the screen! (Sort of).
@TR: any comment on how it performs with normal, non HD, broadcasts? How does the picture look blown up or using the various framing options? Wouldn't a 16:9 TV programme get 'lost' in all the black bars?
Also, another shop was running the disaster film 2012. Again, incredible pictures. But in one scene with the foreign heads of state, the Philips didn't display the subtitles, whereas the 16:9 sets did. Does the 21:9 format get rid of subtitles altogether? (Not much fun for fans of foreign cinema) Can it be set to display them whilst keeping the 21:9 format or is a special (i.e. Philips DVD or Blu-ray player) needed?
It may seem like an odd conclusion to derive from looking at this product but I could really see myself wanting something like this as a PC monitor if they scaled it down and increased the resolution. Given that I use my desktop mostly for either browsing, writing or watching films it would be fantastic to be have room for 3 simultaneous windows so I can browse, write notes and use Word/Tweetdeck/Kindle at the same time, and then be able to use the whole screen estate for films later. Granted it's not a large market and I'd be one of a few to want it but if someone made an affordable ~27" 21:9 monitor I'd struggle to stop myself buying it.
@Ripsmorter: But in one scene with the foreign heads of state, the Philips didn't display the subtitles
Did it have black bars down the left and right, if not then they most likely set the displaymode to zoom or something similar, this then would crop the top and bottom. With 16/9 material there is no way of displaying fullscreen without either having the black bars, or cropping, or worst of all stretching (IOW: make people look fat) :)
I'm surprised you don't anywhere in the review address what this TV is like with regular 16:9 programming.
Not many people would consider having both a 16:9 and 21:9 58" TV in their living rooms; and though this TV obviously targets the movie fanatic, they are still likely to watch a fair measure of regular 16:9 news, sports, drama, etc. Perhaps also to connect a games console.
Philips says, "For 16:9 we use highly advanced auto-formatting technology to stretch the 16:9 content progressively out to fill the 21:9 screen. This technology achieves this result with minimal distortion to the image."
Trusted Reviews says nothing.
So how offensive is their "highly advanced auto-formatting" when stretching 16:9 programming to fill a 21:9 display? Is it best turned off, and then is this TV really not suitable except as a dedicated movie TV?
Also, your statement about "manipulating the image's geometry at its left and right edges" when viewing 2.35:1 Blu-rays encoded as letterboxed 16:9 is surely confused. These sources will be upscaled without geometry manipulation; anything else would defeat the purpose of having a TV with a native cinema aspect ratio.
Apologies if this has been mentioned elsewhere but is that creepy camp looking robot on the TV a slim Eric Roberts in disguise?
Although it won't be helpful for TV broadcasted films with subtitles, some Blu-Ray/DVD players can shift the subtitles up on screen to get around the issue of them dropping off the bottom. I have an Oppo BDP-83 and it has this feature in newer firmware revisions.
No so alone a88. I would also love a (say?) 30" version as a PC monitor. It would beat using two monitors as I do now.
But, it would have to be ips, or at least va quality screen. TN sucks. Ergo not that cheap. Incidentally I have to say I'm surprised and dissappointed there's no IPS or VA screen with 3d capability.
I think in future we'll see curved oleds in this size. It makes sense to me.
Credit to Ripsnorter because the very worrying subtitles issue affects even those who can live without them.
Many film distributors cut down on home video costs by using prints before any text - translations, on screen place names, etc. - are part of the final image, and just have it all handled by player generated captions, rejigged appropriately for each region. That's important because unlike the original text, player-generated captions aren't just hideous to look at but are much more frequently placed in the black bar area. And obviously, the implications for anamorphic foreign films are especially bad.
Yeah, I'm curious of that too. The predecessor claimed the same thing. And I'm thinking: it's either gonna be distorted like hell or you're gonna lose a lot of picture information to the left and right. Maybe they do a little of both and reviews of the former model stated that 16:9 looked okay.
Still, I actually like contemporary TV shows better than movies and they're all shot in 16:9, so I'd rather have a 65" 16:9 TV than this one. And that 65" 16:9 TV will probably be just as wide as a 58" 21:9 model, so I'd have the best of both worlds...
The Philips displayed 2012 with no black bars whatsover. The 16:9 ones had them top and bottom as usual. I can't say what ratio the film had on the lu-ray that was playing.
Thanks. I watch a great deal of foreign cinema and will always go for subtitles because I want to hear the original language. Unlike most people (read, Americans) I've no problem watching and reading at the same time. But if the Philips cannot display subtitles in a meaningful way, either from disc or TV, then it's a complete no-deal for me. I can't believe this hasn't occurred to Philips.
@Jones - Ever tried tineye.com reverse image lookup? It's interesting technology. And it does resolve the burning Eric Roberts question! (It's a short called "The Gift" commissioned by Philips to promote the 21:9 aspect ratio... there is some talk it might get picked up by a studio and made into a feature.)
@Tim - Yup, that's my concern.
I bought my last large TV on the basis my viewing would be almost all movies. But the idea that I'd watch a few good films a week fizzled out when I'd run through the classics and acquainted myself with the waste-of-space quality of much of what's being released now.
And at the same time there is some quite well-crafted TV out there, so the balance of my viewing didn't end up as I expected.
And if the Philips 21:9 is really only suitable for movies, I'd be tempted to get a ceiling-mounted projector instead and stick with a regular 16:9 TV.
@Ripsnorter : bit harsh there mate. One should note that the germans and the spanish dub all their foreign tv and movies, whereas the portuguese and scandinavians do not. And they all watch stacks of foreign language (in this case english) films. I don't know about the yanks, but as a kid to now I've noticed things have moved away from dubbing in the english speaking world, I could be wrong, but I doubt the americans are dubbing any foreign movies now.....anyone actually know this?
Not really. If a film is made in German or Spanish or whatever, I want to have the original soundtrack and read subtitles. Dubbing can be done well (the German 'Bruce Willis' is excellent, for example), but someone has translated the script, adapted it because some things don't work in the new language (such as wordplay) and then it's revoiced in a studio. Often, due to pressure of release dates, the voiceover artists, many of whom are jobbing actors, don't even get to see the film as they dub. Also, to save money in the dubbing territories it is conveyor belt work, often done in one take with the dubbing studios competing on the basis of lowest price wins because the distributors don't want to pay a penny more than they have to.
Dubbing is a cultural thing. It was introduced in Germany after the last war by the Americans who wanted to get their films out, and also to counter the Russian films in the eastern zone.
Foreign films get very little play in the US. In the major cities, in some arthouse cinemas, perhaps they have a chance. But mainstream? Not a chance! Let The Right One In, the Scandinavian vampire film, for example, managed to get a lot of publicity and did very well, but actual viewing figures were low. The Americans much prefer to remake a successful (in its own territory) foreign film and then sell it back to us.
Well last year these sets were £4k at launch. A month / two ago they were £1600 in Richer sounds. So if you really like the idea, but aren't too sure then wait a while and pickup a bargain later.
Besides it's CES soon and then we get to find out about all the new toys for next year.
Hi all. Just a couple of questions before I start looking for the best deals.
1. Can you feed in native resolution (2560 x 1080) through HDMI from a PC?
2. What is the input lag like? With and without PC Mode enabled.
@John Archer / TR
Given there are some very relevant questions being asked in this thread (and not just and issues raised, would it be possible for you or someone else to revist this set or comment as best you can?
@John Archer
Well thanks for taking your time to review the 58PFL995. Perhaps it would have been better to not, if you realy make a review, I think it should be done trustworthy and usefull, else dont.
The review dosnt mention a word on key issues - its a long jolly good story.
1) How does it perform detecting the film formats ?
2) How long time to detech a 21:9 movie ?
3) What happens if a 16:9 commercial cuts in ?
4) Can it detect a 21:9 movie even there is a channel logo etc overlapping ?
5) How does it perform on DVD / DVB-T 21:9 movies ????
Those questions are key.
Aparantly the new 58PFL9955 has a menu for moving the subtitles. Check theese 29 pictures on a Vorwegian test, among one ( column 1, row 3 ) with the menu for moving the subtitles. "Flytting av undertext" = "Move subtitles". I suppose there should be a picture of this in the manual.
How Philips communicates about the Philips Cinema 21:9 58PFL9955H
More information -
Trusted Reviews is part of the Time Inc. (UK) Ltd Technology Network
Get TrustedReviews' award-winning reviews and advice delivered to your inbox for free!


text:
The other morning, I came across a tweet from a self-identified "theobrogian," calling for ex-fundamentalist bloggers to "stop making a career out of bitterness."The first thing I thought was, who the hell is hiring people to be bitter? Is that a skill I can list on my resume? That would be my dream job! My second thought was that this is hardly original. I've been called bitter more times than I can count. Even before I started a blog that focuses on calling out abuse in Christi … [Read more...]
Beautiful, Beautiful Bitterness
Why Do We Blame the Victim?: We Don't Want to Face Our Responsibility and Privilege
This is post number two in a series I'm working on about why we tend to blame victims in our society. My church has been covering this topic in it's latest sermon series (which you can listen to online). Also, I've been taking a seminary class on the Psalms and Wisdom Literature, which contain some interesting, and often contradictory messages about victim blaming.In my first post in this series, I discussed one possible reason for why we blame victims: We are afraid of a world outside of … [Read more...]
N.T. Wright: A Follow-Up
I'm still getting interesting responses to the post on N.T. Wright and marriage equality that I wrote a couple of weeks ago. N.T. Wright fans can get vicious, y'all. I don't think I've ever gotten death threats from Nazi sympathizers on here before (and I've had my blog linked both to Reddit Men's Rights, and Douglas Wilson's blog, so that's saying something). Skipping over the troll comments, I thought I'd tackle some of the more "serious" responses in this follow-up post. Fuckin' Analogies! … [Read more...]
On Proverbs, Job, and Why Victim Blaming is Next to Blasphemy
I've been taking a class on the Psalms and Wisdom Literature, and reading both the books of Job and the books of Proverbs, which seem to take a drastically different approach to the topic of blaming victims.Proverbs is filled with statements about the way the world supposedly works: People who despise advice will find themselves in trouble; those who respect it will succeed (13:13)Poor is he who works with a negligent hand, But the hand of the diligent makes rich. (10:4)Commit your … [Read more...]
More Like N.T. Wrong, Amirite?: How N.T. Wright's Bigotry Causes Him To Contradict His Own Theology
In case you haven't heard, N.T. Wright--author of theology books such as Surprised By Hope and Simply Christian, and former Bishop of Durham--recently did an interview in which he compared people who support marriage equality to Nazis and Soviet Communists.Nazis.And Soviet Communists.While I'm not surprised that Wright is not on board with marriage equality (he's brought up his opposition to LGB people in several other places), I was a little shocked to hear a man who is considered, a … [Read more...]
A Benediction for My Fellow Queer Christians
For personal safety reasons, I'm going to ask anyone who chooses to share this post to please not tag me on any social media sites. Thank you. ______________It's not a sin to be gay, lesbian, or bisexual. And I don't mean it like some folk mean it--"It's not a sin to be gay! Just to act on your gayness." To quote my grandmother-in-law, "That's horse piss!" Acting gay, lesbian, or bisexual--finding members of your own sex attractive; crushing on, dating, marrying, flirting with, and/or sl … [Read more...]
Modest Is Hottest: A Guest Post for No Shame Movement
Today, I'm over at No Shame Movement sharing my story about growing up in Christian purity culture. Check it out! Also, be sure to read the other stories at NSM, and follow No Shame Movement on Twitter! "What would happen if I bought this shirt three sizes too small?" I joked to my sister, as we waited for my mom to finish up her shopping at the Christian bookstore. The shirt in question was a woman's tee shirt with the words "Modest Is Hottest" across the front.The sizes seemed to line up w … [Read more...]
Loving My Mind for Lent.
Last year, during Lent, I wrote what would turn out to be one of my most popular blog posts of all time. In this post, "Loving My Body for Lent," I decided that for Lent, I would give up the harmful teachings I'd inherited from purity culture, and I would take on a new attitude toward my own body. I'm setting it free from the hatred that I have directed toward it for years and years. I'm setting it free from any responsibility that the church tries to put on it for the sins of men. I'm setting i … [Read more...]
The Answer To Sexual Shame is Not MORE Sexual Shame, Carson T. Clark
[Content Note: Sexual and Spiritual Abuse]When I was 16, I dated an abuser who was constantly coercing me into having sex with him. I had been raised in fundamentalist purity culture, so I thought of sex as something gross and scary. My boyfriend at the time tried to combat those feelings by sending me on guilt trips and by holding me to his manipulative, subjective standards of "responsibility."He'd say things like, "You hugging me turned me on. You're a horrible person if you turn a … [Read more...]
Why I'd Choose Conservative Christianity Over Amanda Marcotte's Feminism
[Content Note: Rape, Victim Blaming, Unjust Arrest]This Monday, popular feminist writer Amanda Marcotte wrote a decent piece for Salon, describing victim blaming in conservative Christianity. In it, she pointed out that in many conservative Christian circles... "...[m]en's choices, especially men's sexual choices, are the responsibility of women. So if a man chooses to rape you, it's understood not as him asserting dominance over you, but as the man taking the liberties you must have extende … [Read more...]


text:
Ah---the true meaning of a Glock. The G19 is next on my list. First time I get a crack at one for $400 or less, it's mine! Glock on!
went to the range this past weekend with a friend, and i took my taurus pt145, my hi point .380, and of course my Glock 19. after 500 rounds the high point hasnt given any problems at all. after 300 rounds the pt145 only gave me one problem, the slide stop would be pushed out to the side of the slide. sent it in and it is why i only have 300 rounds through it. they took a long while to get it back to me.
as for my glock, i just got it about 4 months ago, and i got to tell you, i have put 600 rounds through it, and it works like a dream. i was aming at the center red spot and i tried to shoot it out and i did. took about 150 rounds with my pt145 and the glock but the glock did the most damage. that is the one firearm that i keep next to my bed. i had to cock it once when my wife heard our cat playin with the door to the garage and she woke me up unexpectly. she said, hurry up get up the door, the door. i sprang up still asleep grabbed my Glock 19 cocked it and had it at the ready, still half asleep and not having my wits about me. then i finally realized what was goin on and i went to see what was messing with the door and i ended up shooting my cat. hahahaha, im kidding, i still had my glock at the ready though. moral of my story, i dont think i wouldve jumped out of bed fast enough and loaded a round still not fully awake and aware of what is going on with another handgun.
Ah---the true meaning of a Glock. The G19 is next on my list. First time I get a crack at one for $400 or less, it's mine! Glock on!
I really want a G19, too, someday. I love my 92 but she's a big girl, so I wouldn't mind a smaller 9 that's easy to travel with.
I've had a similar situation with my dumb cat. My girl and I were sleeping and the cat got a plastic bag handle wrapped around its neck. So, it was freaking out running all over the place knocking things over. It woke us up and we didn't know it was him, so I grabbed my XD45, gave the 92 to my girl, and went exploring.
Needless to say I was very relieved to find out it was him. I took his head out of the handle, gave him a little kick in the butt, and we went back to bed. Stupid cat.
stupid cats. i was in a good deep sleep, and then i couldnt go back to sleep. i had to finish the movie i turned off cause i was sleepy. im goin to shoot him next time and tell my wife i thought it was an actual person breaking in. lol.
I'm more of a .40S&W type. But glad to hear another passionate Glock member.
Be nice to the cats and be mean to Bad guys.
you know, all these years that i have shot handguns, i have never shot a 40 s&w. it has always been, .380, 9mm, and .45. but i might get a glock 23 to go with my g19.
hell yeah im passionate about glock. can get a better feel quicker and shoot as good with one. it may not look appealing to everyone, but to me it is a sexy looking gun.
hahaha, my cat likes me so i guess i will spare him. if someone would break in and messes with the cat he will have to contend with two very family protective boxers, a glock 19 to the head and a taurus pt145 to the chest.
that's good to hear that you love your g19, picking mine up this coming friday. have fun
I have the glock 19 and the 36. The 36 hasn't really come up to speed yet but the glock 19 with about 800 rounds has really broken in really nice. I added the Glock factory tactical light/laser combo. If you don't have a light/laser get one
Makes those midnight noises that you spring out of bed for a bit more sane.
Plus... a super bright light with a laser is typically bad news for the bad guy.
I rented a 19 at the range this morning and really liked and enjoyed it. Think it needs to be added to my compact collection of one so far, S&W M&P 9c. A more experienced shooter with me had never fired any Glock before (is there anyone else left who hasn't?) and he also really enjoyed the 19.


text:
The Japanese Dental Science Review is published by the Japanese Association for Dental Science aiming to introduce the modern aspects of the dental sciences from Japan more comprehensively and comparatively in the tide of the world dentistry and contribute to the development of dental basic and clinical sciences in the world, and to share and discuss the update information with foreign researchers and dentists for further development of dentistry.
The Japanese Dental Science Review is unique journal devoted Review paper - many of which are invited, but unsolicited submissions are welcome and will be given full consideration. All submitted papers are subject to the peer- refereeing process.
The Japanese Dental Science Review is an open access journal and the journal will bear the cost of publication for all articles.Submission of an article implies that the work described has not been published previously in its present form (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.
For inquiries regarding your paper or the publishing process in general, please contact the editorial office at email@example.com for reviews: Please supply the names of at least two potential reviewers for your manuscript. Please do not suggest reviewers from your own institution, previous or current collaborators. Suggested reviewers must also have published a paper on the same topic in a peer-reviewed journal. Please provide full names, institutions and email addresses of suggested reviewers. Please note, the final choice of reviewers is that of the Editor and the journal reserves the right not to use reviewers which have been suggested by the authors.
Work on human beings that is submitted to the Japanese Dental Science Review should conform to the principles laid down in the Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects, adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The manuscript should contain a statement that the work has been approved by the appropriate ethics committees related to the institution(s) in which it was performed and that subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in accordance with institution guidelines. Patients' and volunteers' names, initials, and hospital numbers should not be used.
This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. For more information on the types of peer review, please visit: https://www.elsevier.com/reviewers/peer-review.
Role of corresponding author:
The corresponding author of a manuscript for the Japanese Dental Science Review has the duty to ensure that all the named authors have seen and approved the original and any revised version of the paper and are in agreement with its content before it is submitted to the Editorial Office. Each author should have participated sufficiently in the work to take public responsibility for the content. The corresponding author should also ensure that all those who have contributed to the research are acknowledged appropriately either as a co-author or in the Acknowledgements. In addition, the corresponding author has the prime responsibility for ensuring the paper is correctly prepared according to the Guide for Authors. Submitted manuscripts not complying with the Guide for Authors may be returned to the authors for possible revision and resubmission.
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Oxford, UK: phone (+44) 1865 843830, fax (+44) 1865 853333, e-mail firstname.lastname@example.com. Requests may also be completed online via the Elsevier homepage (http://www.elsevier.com/locate/permissions).
Online Submission of Manuscripts: http://ees.elsevier.com/jdsr
Submission and peer review of all papers is now conducted entirely online using the dedicated site at http://ees.elsevier.com/jdsr
Authors are required to register upon using the system for the first time. Authors are guided stepwise through the entire process, and are kept abreast of the progress of their paper at each stage.
The system creates a PDF version of the submitted manuscript for peer review, revision and proofing. All correspondence, including the Editor's decision and request for revisions, is conducted by e-mail.
Please note that even though manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance.
Authors requesting further information on online submission are strongly encouraged to view an online tutorial, at http://ees.elsevier.com/jdsr.For additional queries please visit our Support Center.
Global telephone support is available for e-submission 24/7:
For The Americas: +1 888 834 7287 (toll-free for US & Canadian customers)
For Asia & Pacific: +81 3 5561 5032
For Europe & rest of the world: +353 61 709190
Title page: Please provide the following data on the title page (in the order given).
1) Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
2) Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.
3) Corresponding author. Clearly indicate who is willing to handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
4) Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a
Present address (or
Permanent address) may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
5) Running title. An abbreviated title (within 10 words) for use as a running title.
6) Scientific field of dental Science: Indicate specialized field of dental science which your paper is involving.
7) Article type: Indicate article type such as "Review Article", "Letter to Editors".
Keyword: Immediately after the abstract, provide a maximum of 6 keywords, avoiding general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.MAIN TEXT
Review Article: Reviews may concern either clinical or laboratory scientific topics. Standard length of review article is between 3,000 and 6,500 words.Letters to the Editor. These should be up to 600 words in length, and should be submitted in response to material published in the journal to make small clinical points or to introduce a point of view. They can be accompanied by up to 5 references but no illustrations. Letters do not carry an abstract.
Abbreviations: Define abbreviations that are not standard in this field at their first occurrence in the article: in the abstract but also in the main text after it. Ensure consistency of abbreviations throughout the article.Subdivision of the article: Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2,), 1.2, etc. (the abstract is not included in section numbering). Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Conflict of interest: All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. See also https://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing.Role of the funding source: All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.
Acknowledgements: All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.Figures: Number tables consecutively in accordance with their appearance in the text. Figure legends should be listed on separate page. High-resolution graphics files must always be provided separate from the main text file (see http://ees.elsevier.com/cpr for full instructions, including other supplementary files such as high-resolution images, movies, animation sequences, background datasets, sound clips and more).
Tables: Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.REFERENCES:
References to literature must be indicated by Arabic numerals in square parentheses which run consecutively through the paper. Where a reference is cited more than once in the text the same number should be used each time. Reference style should follow the "Vancouver" style described in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals." Update October 2007. Further information can be found at www.icmje.org. The titles of journals should be abbreviated according to the style used in Index Medicus.
(1) List all authors or editors, but if there are more than six list first six plus et al.;
(2) Full first and last page numbers of articles should be provided. Unpublished data and personal communications should be given in round parentheses in the text and not as references.
(3) To refer to a book or journal article written in Japanese, the phrase "(in Japanese)" or "(in Japanese with English abstract)" should be added.
Reference Style for Journals:
[1] Inoue S, Koshiro K, Yoshida Y, De Munch J, Nagakane K, Suzuki K, et al. Hydrolytic stability of self-etch adhesives bonded to dentin. J Dent Res 2005;84:1160-1164.
[2] Ban S. All ceramic crown: Evaluation of mechanical properties. J Dent Eng 2002;140:9-12 (in Japanese).
Reference Style for Books:
[3] Hersen M (editor). Comprehensive handbook of behavioral assessment (2 volumes). New York: Academic Press (Elsevier Science); 2005.
[4] Karchmer AW. Infective endocarditis. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease: a textbook of cardiovascular medicine. 6th ed., Philadelphia: W.B. Saunders; 1996, p. 1723-1750.
[5] Sloss EAC, Southard KA, Qian F, Stock SE, Mann KR, Meyer DL, et al. Comparison of soft-tissue profiles after treatment with headgear or Herbst appliance. Am J Orthod Dentofacial Orthop. Available online 8 April 2008 from doi:10.1016/j.ajodo.2006.04.050.For Articles in Press, please do not include an "In Press" denotation to your citation. When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
US National Institutes of Health (NIH) voluntary posting ("Public Access") policy
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy", see http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at firstname.lastname@example.com) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Preparation of illustrations:General points
—Make sure you use uniform lettering and sizing of your original artwork.
—Save text in illustrations as "graphics" or enclose the font.
—Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol.
—Number the illustrations according to their sequence in the text.
—Use a logical naming convention for your artwork files.
—Produce images near to the desired size of the printed version.
A detailed guide on electronic artwork is available on our website:
Regardless of the application used, when your electronic artwork is finalized, please "save as" or convert the images to one of the following formats (Note the resolution requirements for line drawings, halftones, and line/halftone combinations given below.):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: Colour or greyscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
—Supply embedded graphics in your word processor (spreadsheet, presentation) document;
—Supply files that are optimized for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
—Supply files that are too low in resolution;
—Submit graphics that are disproportionately large for the content.
Colour illustrationsPlease make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable colour figures, Elsevier will ensure that these figures will appear in colour completely free-of-charge in the electronic version of your paper (e.g., ScienceDirect), regardless of whether or not these illustrations are reproduced in colour in the printed version. Colour illustrations can only be included in print if the additional cost of reproduction (EUR 400 for the first page, and EUR 300 for the second and subsequent pages) is contributed by the author: you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting colour figures to "grayscale" (for the printed version should you not opt for colour in print) please submit in addition usable black and white versions of all the colour illustrations.Proofs
One set of page proofs in PDF format will be sent by e-mail to the corresponding author. Authors are requested to return corrections by e-mail or fax within 48 hours. Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win. If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post.Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
Author BenefitsNo page charges: Publishing in the Japanese Dental Science Review is free.
Fast online publication: Accepted articles will be published online in press, corrected proof version. These articles can be cited by doi.Free offprints: Twenty-five free offprints of each article will be supplied. Additional offprints can be ordered at the price shown on the offprint order form.
For complete up-to-date addresses of Editors please click on the link to Editors.


text:
A reminder that on the 1st of January I started a new 365 project for 2013.
This is called the GEOLIBRARY.
I am planning to put up a blog post each day this year about a book that is on my shelves which I think that geography teachers in particular (although of course they can also be read by anyone else!!) would find useful in some way...
Just over 3 weeks in and we have already put an eclectic mix of books on the shelves of the GeoLibrary, but there is still room for plenty more.
We have fiction and non-fiction, travel books, books on various countries and themes and some cultural history too.
Check out what's already been placed on the shelves of the GeoLibrary
I will be writing a 'librarian's report' at the end of each month and am happy to receive suggestions for other books, or reviews of existing books added as comments (for example)
We never close....


text:
Property/Reservations Manager, Menehune House and Menehune Cottage, Realtor (S), UpCountry Realty
Showing all 0 rentals in :
Copyright © 2017, FlipKey Inc. All rights reserved.
As featured in USA TODAY and recommended by Travel + Leisure in its annual Villa Guide:
FlipKey is a vacation rental marketplace with more than 300,000 homes and rooms around the world. Find the perfect place to stay for your trip, and get great value along with the space, privacy and amenities of home.
Find the vacation rental perfect for you. Learn how.


text:
EXPLORE! To the Moon and Beyond with NASA's LRO Mission
Differentiation Demonstration: Moon
Correlations to National Science Standards
Grades K– 4
Physical Science – Content Standard B
Properties of Objects and Materials
- Objects have many observable properties, including size, weight, shape, color, temperature, and the ability to react with other substances.
- Materials can exist in different states — solid, liquid, and gas. Some common materials, such as water, can be changed from one state to another by heating or cooling.
Science and Technology – Content Standard E
Understanding About Science and Technology
- People have always had questions about their world. Science is one way of answering questions and explaining the natural world.
History and Nature of Science – Content Standard G
Science as a Human Endeavor
- Although men and women using scientific inquiry have learned much about objects, evens, and phenomena in nature, much more remains to be understood. Science will never be finished.
Grades 5– 8
Science as Inquiry – Content Standard A
Abilities Necessary to Do Scientific Inquiry
- Scientific explanations emphasize evidence, have logically consistent arguments, and use scientific principles, models, and theories. The scientific community accepts and uses such explanations until displaced by better scientific ones. When such displacement occurs, science advances.
Earth and Space Science – Content Standard D
Structure of the Earth System
- The solid earth is layered with a lithosphere; hot, convecting mantle; and dense, metallic core.
History and Nature of Science – Content Standard G
Nature of Science
Science as a Human Endeavor
Last updated
August 27, 2010
August 27, 2010


text: I need to go shopping, I have 11 in my gun and 9 in my spare mag. That was my box of Speer gold dots that I bought with the gun. Trying to get some Federal HST's but they're backordered everywhere. Guess I need to go shopping tomorow. I've been meaning to go get more ammo. Reminds me I need to get to the range as well.


text:
Small-Cap Ideas with Double-Digit Growth Potential: Frederick Rick Wise
Small-Cap Ideas with Double-Digit Growth Potential: Frederick Rick Wise
Source: George S. Mack of The Life Sciences Report (4/5/12)
You can own large medtech and diversified medical supply companies for low volatility and incremental upside in a trending economy (yawn. . .), but small- and mid-cap companies offer the real double-digit growth possibilities. In this exclusive interview with The Life Sciences Report, Analyst and Managing Director Frederick Rick Wise of Leerink Swann shares small-cap ideas that could wake up investors' portfolios.
The Life Sciences Report: Back in early March you attended the 2012 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting in San Diego. Were there topics or companies that the physicians were especially interested in?
Frederick Wise: Whether in a consumer setting or a medical meeting, doctors are drawn to what's new, just like consumers would be. Physicians want to see innovative technologies and understand them. There is a competitive element to it, and two of the biggest companies in the general surgery space were there: Covidien Ltd. (COV:NYSE ) and Johnson & Johnson (JNJ:NYSE) Ethicon Endo-Surgery. Both were displaying a number of new surgical products. I would say that one of the most exciting innovations right now in the medical technology space is in robotics, and for that reason there was a great deal of interest at SAGES in Intuitive Surgical Inc. (ISRG:NASDAQ), which is in the earliest stages of taking its da Vinci robot into the field of general surgery. That's a hot topic for sure.
TLSR: You follow the large-cap diversified supply and device companies. Every recession brings a shakeout that creates efficiencies in business. Have you seen this occur?
FW: That is a crucial point when thinking about this industry today. Virtually every large company I follow has, in some way, shape or form, announced formal restructurings, increases in efficiencies and headcount reduction. Many have combined business units and are looking for efficiencies in terms of manufacturing, distribution or sourcing among other factors.
TLSR: When the economy and employment recover and when patients return for the elective procedures they've been putting off, will these large companies be better positioned than they were in the past?
FW: Yes, I think the large-cap mature companies are moving past many of the obvious negatives and challenges, and are extremely well positioned to show some positive sales and operating leverage as the global economy gradually recovers. Most of these larger companies have market-leading positions in their major markets. All of them are reshaping their portfolios and focusing on more innovative, differentiated products and markets with potentially better pricing, better demand and better margins. We don't have to get back to 15% top-line growth to see leveraged bottom-line growth. Maybe we can get to a point in the recovery where incremental top-line growth of even 12% could produce very positive, very leveraged impacts on the bottom line.
TLSR: With a few exceptions you're basically in the large-cap medical device and diversified supply space. What case do you make for them?
FW: I've never been very fond of generalizing, but I think you have to start from the point that this group has underperformed the broader markets and often the rest of healthcare now for several years. Multiples are low; dividend yields have risen; free cash flow yields are actually at historically high levels. This is all understandable in the context of a maturing industry. I'm inclined to think that in a stable to improving economy, with procedures rebounding, tremendous cash flows, the improved operating leverage I mentioned, and with virtually all large-cap companies increasing dividend payouts, that these could be very attractive total return stories without a lot of risk over the next few years.
TLSR: Clearly, recurring revenue is part of the story for the mega-caps like Johnson & Johnson (J&J), Abbott Laboratories (ABT:NYSE) and even smaller large caps like Baxter International Inc. (BAX:NYSE) and Covidien. But these companies are so widely diversified in their product portfolios that growth is difficult. Also, huge market caps like $90 billion (B) are hard to double. What kind of edge can investors get?
FW: I don't know that there is an edge so to speak, but again, I don't think you have a lot of downside with the large-caps mega companies like J&J, with revenues approaching $70B, and Abbott, approaching $40B. My theme has been to focus on the relatively smaller large-cap companies. In particular, I'm thinking of St. Jude Medical Inc. (STJ:NYSE) and Stryker Corporation (SYK:NYSE) (now followed by another Leerink colleague), both of which have a relatively smaller revenue bases that should be growable, especially given their increasingly attractive portfolios-especially if the business has been run well and if their pipelines are growing and expanding. That happens to be the case with both of these companies.
TLSR: Speaking now to the mid-cap and small-cap companies in your coverage, is consolidation part of your theme?
FW: As I said, one of my themes is the low-risk, total-return concept. A second theme is buying the larger-cap companies with the best pipelines, but with a relatively small revenue basis and that are able to grow faster than the group average-like St. Jude Medical and Stryker. My last major theme is in the direction you suggest: consolidation.
TLSR: May we speak about some of your recommendations for investors? Let's talk about specific companies.
FW: I'm going to start with two companies I just initiated coverage on that I'm very excited about. These are at the opposite end of the spectrum from J&J, Abbott, Medtronic Inc. (MDT:NYSE), Boston Scientific Corp. (BSX:NYSE) and St. Jude.
First, I would like to mention AtriCure Inc. (ATRC:NASDAQ), the market leader in the surgical treatment of atrial fibrillation (AF), with roughly half of the surgical AF market.
TLSR: We're talking about atrial ablation, correct?
FW: Right, but ablation in a surgical setting. Atrial fibrillation, as you know, is a complex and very serious disease. The idea is that you burn lines in the heart tissue to stop the cascade of heart cell contractions, which is a harmful process that almost is like dominos falling, but in a chaotic fashion. With these burn lines, or lines of block, you prevent the electrical arrhythmias from running all over the heart, and if you are successful, you force them back into more regular patterns. Electrophysiologists do atrial ablation procedures as a catheter-based procedure from inside the heart. But, cardiac surgeons have a major opportunity to treat AF from outside the heart. And if you're doing coronary artery bypass graft (CABG) or valve replacement or repair procedures, with the chest open, you've got open access to treat the AF.
TLSR: What's the size of this market?
FW: In the U.S. alone, again just looking at the AF procedures done surgically, atrial ablation done with open-heart procedures could easily be a $250 million (M) market. In round numbers, there are about 350,000 (350K) CABGs done annually in the United States alone, and obviously a lot more internationally. Probably a quarter of them-or about 85K-are performed on patients who have AF, which is not surprising since older people, ages 60-80, tend to have multiple co-morbidities, multiple clinical issues. Of the 85K potential cases of AF, fewer than 20% of them are actually treated during a surgical procedure, despite the fact that it's very well documented in clinical studies that approximately 80-90% of these patients are cured if their AF is treated during surgery. Patients can even stop taking anticoagulants, which are expensive and produce complicating side effects that make it difficult for physicians to manage other co-morbidities. This is a great procedure.
TLSR: Rick, in December Atricure received FDA approval for an expanded AF indication for its Isolator Synergy Surgical Ablation system. You have written that this should drive growth, but the stock didn't react particularly favorably, or for that matter unfavorably.
FW: I'm glad you asked about that because it's important to reflect on the challenges AtriCure faces, as well as the opportunities. Historically, for a couple of reasons, the company was not able to optimally train and educate doctors about its atrial fibrillation treatment. Cardiac surgeons got excited about this approach to AF in the days before AtriCure became public in August 2005. Then the company faced a very challenging period from 2008 to 2010, when the Department of Justice (DOJ) and the U.S. Food and Drug Administration (FDA) stepped up enforcement on off-label promotion of medical products and drugs for all healthcare companies. Unfortunately, AtriCure was one of the first companies to feel the ramifications of this stepped-up enforcement. They weren't doing anything terrible, and their products were approved, but approved for general approaches to cardiac ablating procedures, rather than for specific targeted procedures, and not specifically for atrial fibrillation use. And so again the FDA decided to raise the bar, not just for AtriCure, but for everybody. We've also seen this same raising of the regulatory bar in the spine/orthopedic arm of the industry, for example. For Atricure, this process understandably changed the company's approach to training and education. The very good news for the company is that this DOJ investigation was fully resolved in 2010. Having been the first in, if you will, AtriCure is also now, in a sense, the first out. Now Atricure is the only company with an AF device specifically approved and labeled for educating and training doctors in atrial ablation, etc.
Having said all that, frankly, I can understand why investors are in a show me mode relative to the stock. Especially since I'm in that mode, too. But I believe the company is well positioned to show me-and show the rest of the investment community-that they have a real opportunity to drive surgical AF procedure penetration. It's like baking a cake in a way. If you have got all the ingredients-flour, sugar, butter, etc.-you can turn those ingredients into something very special. Although it will take a few quarters to see it show up in revenues, I think there's an above average chance that we'll see all the ingredients coming together to bake up something very tasty at AtriCure.
TLSR: Training is a major issue. It's important to get new modalities into teaching institutions because established clinicians do not want to take up new procedures. The cardiovascular surgeon wants to graft the new vessels onto the myocardium and get out.
FW: Well said and so true. As in the evolution of all procedures and all technologies, the docs are thinking about what they know from three, five or eight years ago, about earlier generations of these AF products and earlier experiences with less-evolved products and techniques. In the case of surgical atrial ablation, my due diligence suggests that under the best circumstances it can take only an additional five minutes of operating room time to do this procedure successfully. AtriCure's challenge is to bring that message more clearly, succinctly and directly to surgeons, and to help them understand what's possible despite their existing mindsets. This is trench warfare for Atricure-doctor by doctor, hospital by hospital. You can't just put an ad on the screen at the Super Bowl to make this process happen. It's a doc-by-doc training and education process.
TLSR: What was the other company you just initiated coverage on?
FW: The other small-cap company is Unilife Corporation (UNIS:NASDAQ). It's more of a hospital supply-type name, but a very special one. Unilife manufactures prefilled syringes for large pharmaceutical and biotech companies that want to take both new pipeline products, as well as products coming off patent, and package them attractively in a user-friendly, safer way-and in the process meaningfully differentiate their delivery system from others. There's also the important and essential issue of preventing accidental needle sticks for health care workers and patients alike. The company has something like 12 issued patents on their safety and delivery technologies, with a core patent covering the key feature in all of Unilife's safety syringes, revolving around the method of needle retraction within an integrated device.
TLSR: Rick, because these are off-patent drugs and because only a device as been added, can these syringes be approved through the 510(k) process?
FW: The simple answer is yes, but your premise isn't 100% correct. Some are going to be drugs coming off patent, absolutely. But some are going to be drugs in development that can go through all the clinical trials with the Unilife device. Some devices will be approved as a 510(k), some will be approved as part of a device/drug combination.
TLSR: Unilife is a small-cap company, and manufacturing prefilled syringes sounds like a capital-intensive business. I'm curious to know about the drug trials you just referenced. Are the pharma partners going to be paying Unilife for these syringes during the trials? Is the company capitalized well enough to withstand these costs?
FW: Excellent question, because the company has barely any revenue right now. Unilife does have development/customization programs, and it does get paid, but the business is capital-intensive to the extent that it had to build a facility. You have to spend money on equipment to manufacture prototype devices, and the company has done this. Will it need additional capital going forward? The simple answer is probably yes. The complex answer is that maybe it will depend on how the deals are structured and how the cash flows are structured.
TLSR: What else are you talking to investors about currently, Rick?
FW: On the smaller side we continue to like Volcano Corp. (VOLC:NASDAQ). Volcano sees itself today as a very high-level, precision guided therapy company. Volcano already is the global market leader in intravascular ultrasound (IVUS), as well as being one of two key players in the rapidly growing fractional flow reserve (FFR) measurement market. IVUS imaging is used inside the coronary artery before, during and after procedures to better understand both the anatomy and the nature of the blockages inside the artery during percutaneous coronary intervention (PCI) (stent) procedures.
Volcano has had an excellent track record since it became public in 2006. The company has steadily gained market share on a global basis and at the same time has invested heavily in the future. Right now the company has a global installed base of some 6,800 IVUS instruments alone in catheter labs around the world. And at this point, particularly with its latest generation platform, it has the opportunity to expand into other areas of imaging.
As I mentioned, right now both Volcano and St. Jude Medical are benefiting from the very rapid growth and acceptance of fractional flow reserve (FFR) technology, another important diagnostic tool for the catheter lab. It allows for very effective, very simple assessment of coronary artery blockages. Bottom line, right up front doctors get more accurate diagnoses and measurements to determine which patients should get a stent, and whether patients should be stented at all.
TLSR: Is Volcano an acquisition candidate?
FW: I definitely believe Volcano is an acquisition candidate. As a reminder, the other major player in the global IVUS market is Boston Scientific.
TLSR: Is Medtronic in this market?
FW: Medtronic does not offer either IVUS or FFR. Looking at the stent market, Abbott, Boston Scientific, and Medtronic are the three major players in the global stent market. But, of the three, only Boston has IVUS, not FFR, and again, Volcano has both an IVUS and an FFR offering, as well as a full pipeline of new additions to its precision guided therapy portfolio. So, you'd think that could be an interesting portfolio addition at some point.
TLSR: Do you also follow Boston Scientific?
FW: I think it's fair to say it is one of the most controversial large-cap stocks I follow. Boston Scientific has had a very difficult decade. The headwinds that the entire industry has been facing have been doubly or triply challenging for Boston Scientific for a host of reasons. The company very famously paid top dollar for Guidant in April 2006, just as the implantable cardioverter defibrillator (ICD) market slowed precipitously and just as the FDA was raising standards. Expenses were too high and revenues were slowing in a world that was changing dramatically, and the company suddenly found itself overleveraged. It has taken the company time to adapt to the changing environment and its changed circumstances-a process that is far along but still underway.
TLSR: You've got Boston Scientific rated Outperform. Why?
FW: Today, with an entirely new management team in place and with significant restructuring, the last of the major rating agencies has just returned the company's debt to investment grade from a junk rating. The company is generating over $1B/year free cash flow, and the business has now stabilized. It has made significant and important external investments in new and emerging markets, and in products. It very recently made an acquisition that brought with it some differentiated and potentially very exciting ICD technology. I think Boston has positioned itself for much better revenue and earnings-per-share growth over the next three to five years. Its stock has understandably been largely avoided, but over the next one to two years people are going to say, Wow, that's better than I thought, as opposed to the opposite.
TLSR: You alluded to the recent (March) deal to acquire Cameron Health, which has developed a leadless ICD system. How important is a leadless system?
FW: This is a fascinating idea. Cameron has been working to develop this technology over the last decade, and Boston has been an investor from the beginning and has had an option to buy the company for a long time. There were very specific milestones, and Cameron must have met those milestones, based on the decision Boston has made to buy it.
For general background, you need to first appreciate that one of the major challenges in using ICDs is that the leads create many complications. Every major company has had performance challenges with their leads. Having thin wires inside a beating heart for years can take a toll on the products. With traditional ICDs, once the leads are in place they grow into the heart tissue, and it's hard to take them out without a very invasive procedure. If you could develop a product that, for a significant number of patients, could eliminate the need for a lead, the implantation procedure would be made simpler, faster, easier and less complicated. Cameron has done that. Boston has acquired them, and I think Boston could be well ahead of the pack in this respect.
TLSR: At minimum, then, you are thinking Boston Scientific's cardiac rhythm management division could be revived?
FW: A fully approved Cameron device would be transformative to Boston's cardiac rhythm management business. The ability to talk about a unique, and potentially game-changing, technology with hospitals and physicians would enhance Boston's ability to sustain and even gain both market share and physicians' mind share. All this could be quite positive for the company's Customer Relationship Management division outlook.
TLSR: Rick, many thanks to you. I've enjoyed this.
FW: Thank you. My pleasure.
Prior to joining Leerink Swann in 2008, Frederick Rick Wise was a senior managing director and medical supplies and devices analyst with Bear Stearns for 22 years. For the past 13 years, he has been a member of the Institutional Investor All-America Research Team, most recently with a runner-up ranking in the 2009 poll. He was also ranked #4 in the 2006, 2007, and 2008 Greenwich Associates U.S. Equity Analysts poll. Prior to joining Bear Stearns, Wise served as an analyst at Kidder, Peabody & Co. and at Forbes, Inc. Wise received a master's degree and a bachelor's degree from the Manhattan School of Music. He is also a Chartered Financial Analyst.
Want to read more exclusive Life Sciences Report interviews like this? Sign up for our free e-newsletter, and you'll learn when new articles have been published. To see a list of recent interviews with industry analysts and commentators, visit our Exclusive Interviews page.
1) George S. Mack of The Life Sciences Report conducted this interview. He personally and/or his family own shares of the following companies mentioned in this interview: None.
2) The following companies mentioned in the interview are sponsors of The Life Sciences Report: None. Johnson & Johnson (JNJ:NYSE) is not affiliated with Streetwise Reports. Streetwise Reports does not accept stock in exchange for services.
3) Frederick Wise: I personally and/or my family own shares of the following companies mentioned in this interview: Abbott Laboratories (ABT:NYSE). I personally and/or my family am paid by the following companies mentioned in this interview: None. I was not paid by Streetwise Reports for participating in this story.
Streetwise - The Life Sciences Report is Copyright © 2012 by Streetwise Reports LLC. All rights are reserved. Streetwise Reports LLC hereby grants an unrestricted license to use or disseminate this copyrighted material (i) only in whole (and always including this disclaimer), but (ii) never in part.
The Life Sciences Report does not render general or specific investment advice and does not endorse or recommend the business, products, services or securities of any industry or company mentioned in this report.
From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles on the site, may have a long or short position in securities mentioned and may make purchases and/or sales of those securities in the open market or otherwise.
Streetwise Reports LLC does not guarantee the accuracy or thoroughness of the information reported.
Streetwise Reports LLC receives a fee from companies that are listed on the home page in the In This Issue section. Their sponsor pages may be considered advertising for the purposes of 18 U.S.C. 1734.
Participating companies provide the logos used in The Life Sciences Report. These logos are trademarks and are the property of the individual companies.
101 Second St., Suite 110
Petaluma, CA 94952
Tel.: (707) 981-8204
Fax: (707) 981-8998
Email: firstname.lastname@example.com


text: ALISO VIEJO, Calif., Jan. 28, 2013 /PRNewswire/ -- Johnny Rockets has opened its first restaurant in Acton, MA – joining Burlington Mall (that celebrated its 20 th anniversary last May) as the second location in Middlesex County. Restaurants at Boston Logan Airport, Six Flags New England and South Shore Plaza bring Johnny Rockets' Massachusetts total to five. (Logo: http://photos.prnewswire.com/prnh/20120112/LA35131LOGO) As with the nearly 300 Johnny Rockets restaurants around the world, the Acton restaurant offers flavorful fare and friendly service in an ambiance reminiscent of feel-good Americana. Along with juicy Hamburgers, crispy American Fries (served with a ketchup smiley face), hand-spun Shakes and classic Sandwiches, the new restaurant also features localized menu options that include a New England Squealer, Pulled Pork Pickle Sandwich, Sirloin Steak Sandwich and The County Fair – using fresh produce from area farms. "We're thrilled to offer Acton residents and visitors delicious food and a fun dining experience that can't help but make them smile," said Lloyd Sugarman, a Johnny Rockets franchise partner since 1992. Lloyd and son Jason operate 16 locations in Massachusetts, Rhode Island, Minnesota, California, New York, Connecticut and Pennsylvania – partnering with Doug Colenda for the Acton and Burlington (MA), Albany (NY) and Nashville (TN) restaurants. "We're the perfect destination before or after visiting The Faulkner House, Jones Tavern or Children's Discovery Museum … or simply after a day of work, school or running errands. We've got something for everyone." The new restaurant boasts the same clean, contemporary design prototype that Sugarman helped design and first unveiled at his Providence Place restaurant when it was renovated in 2011. Architectural nuances include colorful neon signs, innovative graphics, two-toned red and ivory sleek vinyl upholstery, spoke lighting and other features that add visual interest and comfort. The look is trendy, yet timeless.


text:
Congrats Kris and looking forward to the work coming out of this initiative.
On digital experiences, Open Source, startups & the future
At the Web Services and Context Core initiative sprint earlier this month, we attempted to re-scope the initiative so that it was more manageable and less daunting. We decided to spin off one of the major components of what it was trying to tackle into its own separate initiative, the Layout initiative.
The goal of the Layout initiative is to make all elements on the page into contextual blocks that can be rearranged and organized into flexible layouts (and even layouts within layouts) through a drag and drop interface.
Specifically, the initiative breaks down as:
This approach to building pages yields a number of benefits, including the ability to customize the look and feel of a site based on a variety of contextual information, the ability to render parts of the page independently for performance, increased consistency, and increased flexibility for site builders to re-use page elements in a number of contexts.
I've asked Kris "EclipseGc" Vanderwater to head up the Layout initiative team. Kris has spent a lot of time working with Panels and Page Manager, and intends to work closely with Earl Miles and other maintainers of the CTools suite. Read Kris's blog post for an overview of the initiatives' goals. Note that like all initiatives, they don't actually materialize unless people decide to help. Please join the discussions in the Blocks and Layouts Everywhere Initiative on groups.drupal.org and help work on Layout issues on drupal.org.
Congrats Kris and looking forward to the work coming out of this initiative.
Welcome aboard, Kris! This is crazy important. Let's make it happen.
This will be a great piece of functionality to hit Drupal core.
Hey this sounds like really interesting and a nice evolution of the contextual links concept. Panels is a great concept but, from my experience (which could be biased), not quite ripe for non drupalistas (such as average non technical editors/admins). What your sketching in this post could mean a great leap forward in intuitivity for end user (end editors/admins).
Very nice choice of path...
This looks very interesting. A good decision to separate this from WSCCI!
Cool, this is mouth-watering stuff.
But I feel a little frustrated that I have to wait so long before I can offer it all to my customers.
Great news!
Good luck for the work Kris! Make the context management rock for D8! I'm sure we'll be able to find a proper way to have translatable blocks everywhere too. ;)
OMG! Can d8 even get more awesome?
Drupal 8 isn't awesome at all yet. It's going to take a ton of work to get there, on this and other initiatives. Not just coding, but clearing the road ahead of blockers so that we can work.
This is just a plan for awesome. If you actually want awesome, come help make it awesome.
This is exciting. I always build sites where clients are only just content editor and I never give them access to the block configuration because it's so confusing for them. So I'm definetely willing to help. as much as I can.
Recently I stumbled upon this module that introduces the concept of layouts. I don't think it's really maintained but there might be some code or approach of interest.
Great news. Congrats Chris.
Really nice to see WSCCI sobering up a bit, realizing it can't gobble up the whole bottle :)
Are there other initiatives on the work? Any chance to see some sort of content listing feature in core for D8? It really seems the missing block at this point to offer out of the box functionality for the most common use cases.
D8 is going to rock out of the box with this feature built in. Power layouts with ESI support will take us to a new level of site building for the enterprise.
Congrats! Looking forward to working with you more :)
Cool, this is mouth-watering stuffed. But I feel a little frustrated that I have to wait so long before I can offer it all to my customers.
I think Display Suite might have a lot to offer this initiative. Has a review of contrib modules which might lend to the cause been carried out already?
Can it add into mater repo branch (drupal project). Or a docs page to list all these D8 stuff.
Congrats Kris, this is great news.
I'm just a bit worried seeing Panels and Page Manager being mentioned in this page, because IMHO those tools often seem to be too complex for most lay-out problems. For my own peace of mind, I'll just assume that they were only mentioned to illustrate Kris' knowledge on the subject.
Excellent news, this sounds like a real step in the right direction. Having the ability to choose different layout per page is something we've been hankering for,for a long time.
Can't wait :-)
Updates from Dries straight to your mailbox


text:
"We created business cards for our son with the contact info for myself and my husband. Out son I setting to the age where he is starting to make plans with friends and these have proved an easy way for the other parents to get in touch. He likes them, as well."
"I was thoroughly pleased with these cards. It is certainly a fun little splurge and I look forward to showing them off to my fellow moms. We so often meet moms out and about and talk about play dates. The paper quality is sturdy enough to hold up in my wallet or purse so they are always at the ready!"
"The cards were as cute and perfect as the picture I saw. It was easy to complete my order an fast. The quality of the paper and the color was really amazing!!"
"Bought these to use as play date cards. They look great and I'm so happy with them. The fruit design is really bright and happy. Type looks great."
"I loved my order. It not only came on time but it looked exactly the same as in my computer. The colors were vibrant and I liked the many font options. It was a plus that it was reviewed by a designer at no cost to me. I would totally buy again from Tinyprints."
Copyright © 2004-2017 Shutterfly, Inc | Tiny Prints | Terms of Use. Designated trademarks and brands are the property of their respective owners.


text:
Monster Beats by Dr. Dre Studio headphones were selling for rock-bottom prices on Black Friday -- we even saw a pair of these once-overpriced headphones, which originally sold for $350, for $115. But headphone purists are dismayed at the sound of these flashy cans, mocking their powerful bass as overpowering and artificial. If you feel that way and you're listening to these headphones on an iPhone, iPad or iPod Touch, here's how to equalize their sound to your liking.
[More from Mashable: Here's Ashton Kutcher as Steve Jobs]
By default, iOS devices don't offer the kind of equalizer you would see in a recording studio, giving you control over each tiny slice of the sound spectrum. But they do give you a couple of dozen easy-to-select choices for sound equalization. Among the 24 available settings, you'll probably find one that pleases your ears, not only with Beats Studio headphones, but with any audio playback device you'd like to tailor to your particular tastes.
Follow along in the gallery below, where we show you how to find the settings, and then you can try them out for yourself:
[More from Mashable: iPhone 5 Will Arrive in More Than 50 New Countries This Month]
iPhone EQ Settings
Tap "Settings"
Click here to view this gallery.
This story originally published on Mashable here.


text:
Test Your Start Up Savvy On Your Phone
The Tech Startup Genius app guides users through the stages of starting their own company.
Designed for people looking to start their own tech company, the free mobile app Tech Startup Genius helps users through the early stages with a series of flash cards containing information about important people, organizations and buzz-words they need to know. This new method of business coaching, available for the iPhone and iPad, was developed by entrepreneurs in the New York and Silicon Valley start-up communities.
The iOS app, from Brainscape, can be used to test your knowledge on the go. There are four categories: People you should know, Orgs you should know, Company formation basics, and Fundraising basics. You can either choose a category to answer questions on, select 'Random mix' to answer questions from all of the categories, or search through the flash cards to get a refresher.
After you're shown a question, you tap the screen to flip the card over and see the answer. Then the app asks how well you knew this and you can rate it from 1 (not at all) to 5 (perfectly). If you say you didn't know the answer, the card is thrown back into the mix and will come round later for you to try again.


text:
"Excellent service! Design team assisted with adding an extra line of text as requested. Cards were beautiful and my daughter was so proud of what she chose. Family receiving card were very impressed!"
"So happy with the invites, tiny prints staff so helpful and accommodating, changing them to a colour I really wanted, making sure I was happy. Will be using for all future invitation needs!"
"Love this card. The design is exactly what I am looking for and the quality of the paper is excellent. The card looks and feels like a much more expensive card. It is perfect for my daughter's First Communion. My only suggestion would be to make the design in different colors. I would have loved to choose this design in something other than pink. But I am thrilled with my invitations and would definitely recommend this card."
"i love our invitations. i was surprised by the small size, but thought it was large enough to communicate all that we needed. the pink background is not solid... another surprise, but i like the variance design."
"I love this card! I purchased it for my daughter's first communion. I only wish there were matching products like addresses labels, favor tags and thank you notes. I have searched the entire site for something similar and only 1 thing was even close."
Copyright © 2004-2017 Shutterfly, Inc | Tiny Prints | Terms of Use. Designated trademarks and brands are the property of their respective owners.


text:
Campus Billboard
Stay Classy, Beloit: A Participatory Theater Workshop on Class, Power, and PrivilegeMarch 21, 2012 at 1:45 pmThis workshop is lead by Amy Sarno and Theater for Social Action (TSA) and from 2-3 PM in the Moore Lounge. Amy will lead participants through an image theater activity…
Screening: Sherlock Holmes 2: A Game of ShadowsMarch 20, 2012 at 8:39 pm
Screening: Sherlock Holmes 2: A Game of Shadows
Need a job? Try Bushel & Peck'sMarch 19, 2012 at 10:46 pm
Special Break Meals Hours at CommonsMarch 2, 2012 at 3:10 pm
Saturday Mar. 3 through Sunday Mar. 11
Breakfast every day 7:45am-9:00am (Continental only on Sat. & Sun.)
Lunch Mon. - Fri. 11:30am-1:15pm
Lunch Sat. & Sun. 11:30am-1:00pm
Dinner Mon.-Fri. 4:45pm-6:45pm
Dinner Sat. 4:30pm-6:00pm
Buccaneer Softball and Women's Soccer Sponsor "Kids Night Out"March 2, 2012 at 8:45 am
The Beloit College Softball and Women's Soccer teams are again sponsoring "Kids Night Out" on Friday, March 16.
The program gives parents a night off and gives the kids…
Rockford Career and Internship FairFebruary 29, 2012 at 10:32 am
Transportation to Career Fair in Rockford
Beloit College Swimming & Diving Hosting Water Safety Day March 10February 29, 2012 at 9:29 am
The Beloit College Swimming & Diving team will be hosting the fourth of their Water Safety Days on Saturday, March 10.
The program is for faculty, staff and their…
Applications for Venture Grants due March 1February 29, 2012 at 2:33 am
Applications for the Venture Grants (for sophomores only) awarded by the Initiatives Program are due Thursday, March 1 at 4:00 p.m.
Download the application found at http://www.beloit.edu/initiativesprogram/venture/. Fill it in, save…
Corrected Post: National Eating Disorders Awareness Week--Speaker on Wednesday!February 28, 2012 at 12:19 pm
Correction: Eating Disorders Speaker Wednesday at 7 pm
Open Klezmer Workshop with Kurt BjorlingFebruary 27, 2012 at 10:56 am
World-acclaimed Klezmer musician offering open workshop
Discuss student-athletes and D-III athletics at Beloit!February 21, 2012 at 2:26 pm
Join a discussion about the realities and stereotypes surrounding two student groups at Beloit College -- student-athletes and students who are involved in non-athletic endeavors.
Tuesday 2-21-12
Mathers Lounge (Pearsons Hall)
For the Beloiter film buff, a BIFF scheduleFebruary 16, 2012 at 4:10 pm